Filing Details
- Accession Number:
- 0001209191-21-042665
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-23 08:54:40
- Reporting Period:
- 2021-06-21
- Accepted Time:
- 2021-06-23 08:54:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1323885 | Atricure Inc. | ATRC | Surgical & Medical Instruments & Apparatus (3841) | 341940305 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1666600 | J Justin Noznesky | 7555 Innovation Way Mason OH 45040 | Chief Mktg & Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-21 | 15,000 | $18.30 | 55,808 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-21 | 15,000 | $76.36 | 40,808 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-06-21 | 6,000 | $76.36 | 34,808 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-06-21 | 15,000 | $0.00 | 15,000 | $18.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-01-06 | 2024-01-06 | No | 4 | M | Direct |
Footnotes
- These shares were exercised pursuant to a 10b5-1 trading plan.
- These shares were sold pursuant to a 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $74.11 to $77.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
